Cardiac retention of PET neuronal imaging agent LMI1195 in different species: Impact of norepinephrine uptake-1 and -2 transporters

Nuclear Medicine and Biology

Volumn 40, Issue 5, 2013, Pages 682-688

  Yu, Ming ^a   Bozek, Jody ^a   Kagan, Mikhail ^a   Guaraldi, Mary ^a   Silva, Paula ^a   Azure, Michael ^a   Onthank, David ^a   Robinson, Simon P ^a  

^a Clinical Research   (United States)

Author keywords

18Flourine; Animal species; Cardiac neuronal imaging; Cardiac norepinephrine uptake 1 and 2; PET

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CARRIER PROTEIN; DESIPRAMINE; LMI 1195 F 18; NOREPINEPHRINE UPTAKE 1 TRANSPORTER; NOREPINEPHRINE UPTAKE 2 TRANSPORTER; OXIDOPAMINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CARDIAC IMAGING; CONTROLLED STUDY; DENERVATION; DRUG ACTIVITY; DRUG RETENTION; DRUG UPTAKE; FEMALE; FEMUR; HEART; HEART MUSCLE; HUMAN; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MALE; MUSCLE TISSUE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIMATE; RABBIT; RAT; SPLEEN; SYMPATHETIC NERVE; TISSUE DISTRIBUTION;

3-IODOBENZYLGUANIDINE; ANIMALS; BIOLOGICAL TRANSPORT; DENERVATION; DESIPRAMINE; FLUOROBENZENES; GUANIDINES; HUMANS; KINETICS; MYOCARDIUM; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RATS; SPECIES SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84878204479     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.03.003     Document Type: Article

References (27)

1. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996, 93(9):1667-1676.
2. Bohm M., La Rosee K., Schwinger R.H., Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 1995, 25(1):146-153.
3. Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001, 42(7):1062-1076.
4. Henneman M.M., Bengel F.M., van der Wall E.E., Knuuti J., Bax J.J. Cardiac neuronal imaging: application in the evaluation of cardiac disease. J Nucl Cardiol 2008, 15(3):442-455.
5. Bengel F.M., Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 2004, 11(5):603-616.
6. Jacobson A.F., Senior R., Cerqueira M.D., Wong N.D., Thomas G.S., Lopez V.A., et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010, 55(20):2212-2221.
7. Boogers M.J., Borleffs C.J., Henneman M.M., Van Bommel R.J., van Ramshorst J., Boersma E., et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010, 55(24):2769-2777.
8. Dobbeleir A.A., Hambye A.S., Franken P.R. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice. Eur J Nucl Med 1999, 26(6):655-658.
9. Matsunari I., Aoki H., Nomura Y., Takeda N., Chen W.P., Taki J., et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 2010, 3(5):595-603.
10. Iversen L.L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 1971, 41(4):571-591.
11. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 2001, 91(1):35-62.
12. Carr E.A., Carroll M., Counsell R.E., Tyson J.W. Studies of uptake of the bretylium analogue, iodobenzyltrimethylammonium iodide, by non-primate, monkey and human hearts. Br J Clin Pharmacol 1979, 8(5):425-432.
13. Goldstein D.S., Brush J.E., Eisenhofer G., Stull R., Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation 1988, 78(1):41-48.
14. Dae M.W., De Marco T., Botvinick E.H., O'Connell J.W., Hattner R.S., Huberty J.P., et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts-implications for clinical studies. J Nucl Med 1992, 33(8):1444-1450.
15. Yu M., Bozek J., Lamoy M., Guaraldi M., Silva P., Kagan M., et al. Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 2011, 4(4):435-443.
16. Yu M., Bozek J., Lamoy M., Kagan M., Benites P., Onthank D., et al. LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment. Eur J Nucl Med Mol Imaging 2012, 39(12):1910-1919.
17. Brush J.E., Eisenhofer G., Garty M., Stull R., Maron B.J., Cannon R.O., et al. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 1989, 79(4):836-844.
18. Beau S.L., Saffitz J.E. Transmural heterogeneity of norepinephrine uptake in failing human hearts. J Am Coll Cardiol 1994, 23(3):579-585.
19. Munch G., Rosport K., Bultmann A., Baumgartner C., Li Z., Laacke L., et al. Cardiac overexpression of the norepinephrine transporter uptake-1 results in marked improvement of heart failure. Circ Res 2005, 97(9):928-936.
20. Iversen L.L. The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br J Pharmacol Chemother 1965, 25(1):18-33.
21. Schomig E., Lazar A., Grundemann D. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb Exp Pharmacol 2006, 175:151-180.
22. Glowniak J.V., Wilson R.A., Joyce M.E., Turner F.E. Evaluation of metaiodobenzylguanidine heart and lung extraction fraction by first-pass analysis in pigs. J Nucl Med 1992, 33(5):716-723.
23. Higuchi T., Yousefi B.H., Reder S., Rischpler C., Weidl E., Yu M., et al. F-18 labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts. J Nucl Med 2012, 53(Suppl 1):1771.
24. Rischpler C., Fukushima K., Isoda T., Holt D.P., Dannals R.F., Abraham R., et al. Discrepant uptake of the sympathetic nerve imaging tracers hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts. Circulation 2011, 124:A16604.
25. Counsell R.E., Yu T., Ranade V.V., Buswink A.A., Carr E.A., Carroll M. Radioiodinated bretylium analogs for myocardial scanning. J Nucl Med 1974, 15(11):991-996.
26. Boura A.L., Duncombe W.G., McCoubrey A. The distribution of some quaternary ammonium salts in the peripheral nervous system of cats in relation to the adrenergic blocking action of bretylium. Br J Pharmacol Chemother 1961, 17(1):92-100.
27. Fiebig E.R., Trendelenburg U. The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart. Naunyn Schmiedebergs Arch Pharmacol 1978, 303(1):21-35.